SION - NASDAQ

Sionna Therapeutics, Inc.

SION·NASDAQ

$37.38

+1.8%

HealthcareBiotechnology

Sionna Therapeutics, Inc. is a biopharmaceutical company. The Company provides treatment paradigm for cystic fibrosis patients by developing medicines that normalize the function of the cystic fibrosis transmembrane conductance regulator.

Statements Value Model

At a Glance

Live Snapshot

Market Cap$1.69B

EPS-1.8800

P/E Ratio-19.88

Earnings Date08/10/2026

sion

Cash and Short Term Investments

Last Annual Value

235.88M

3-Year CAGR

42%

5-Year CAGR

23%

10-Year CAGR

11%

Adjust for Inflation

Sionna Therapeutics, Inc. Competitors Analysis of Cash and Short Term Investments

SION · NASDAQ

Company	Cash and Short Term Investments	CAGR 3Y	CAGR 5Y	CAGR 10Y
Sionna Therapeutics, Inc. NASDAQ:SION	235.88M	83.0%	N/A	N/A
Vera Therapeutics, Inc. NASDAQ:VERA	714.59M	64.4%	55.1%	N/A
Janux Therapeutics, Inc. NASDAQ:JANX	966.57M	41.1%	20.9%	N/A
Maze Therapeutics, Inc. NASDAQ:MAZE	341.92M	127.2%	N/A	N/A
Ardelyx, Inc. NASDAQ:ARDX	264.69M	12.8%	17.8%	2.8%
Celldex Therapeutics, Inc. NASDAQ:CLDX	518.57M	7.1%	4.9%	10.6%
Immunome, Inc. NASDAQ:IMNM	653.48M	67.9%	67.7%	N/A
Xeris Biopharma Holdings, Inc. NASDAQ:XERS	111.04M	15.3%	1.6%	13.2%
Biohaven Ltd. NYSE:BHVN	319.14M	-5.8%	33.2%	N/A

Sionna Therapeutics, Inc. Fair Value Envelope

SION · NASDAQ

Our analysis suggests that SION has a fair value of HIDDEN per share in the Base Case projection. With shares currently trading at $37.3752, this represents a potential HIDDEN relative to our calculated worth for Sionna Therapeutics, Inc..

HIDDEN

Intrinsic Value

Current Price: $37.3752

Related Guides

Blog Categories

Continue your SION research with focused valuation guides.

Fundamentals

Decode statement quality and operating durability.

Accounting

Interpret line items with cleaner analytical framing.

Forecasting

Translate historical performance into forward scenarios.

Reference

Use practical frameworks for statement-led valuation.

Research Paths

Pick your next lens

Snapshot

Start with context, operating signals, and key market metrics.

Value Model

Stress test fair value across bear, base, and bull assumptions.

Statements

Validate revenue quality, margins, and balance sheet durability.

Earnings Call

Read management commentary and compare it with reported outcomes.

Dividends

Check payout sustainability and long-term distribution behavior.

Analyst Expectations

Review consensus spread and where estimate risk is concentrated.